- Home
- OFG vs KNSA Comparison
OFG vs KNSA Comparison
Compare OFG & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- KNSA
- Stock Information
- Founded
- OFG 1964
- KNSA 2015
- Country
- OFG United States
- KNSA United Kingdom
- Employees
- OFG N/A
- KNSA N/A
- Industry
- OFG Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- OFG Finance
- KNSA Health Care
- Exchange
- OFG Nasdaq
- KNSA Nasdaq
- Market Cap
- OFG 1.9B
- KNSA 2.1B
- IPO Year
- OFG N/A
- KNSA 2018
- Fundamental
- Price
- OFG $42.98
- KNSA $28.40
- Analyst Decision
- OFG Buy
- KNSA Strong Buy
- Analyst Count
- OFG 3
- KNSA 5
- Target Price
- OFG $44.00
- KNSA $38.80
- AVG Volume (30 Days)
- OFG 252.8K
- KNSA 715.3K
- Earning Date
- OFG 07-17-2025
- KNSA 07-22-2025
- Dividend Yield
- OFG 2.79%
- KNSA N/A
- EPS Growth
- OFG 6.67
- KNSA N/A
- EPS
- OFG 4.18
- KNSA N/A
- Revenue
- OFG $623,009,000.00
- KNSA $481,166,000.00
- Revenue This Year
- OFG $2.30
- KNSA $37.21
- Revenue Next Year
- OFG $2.61
- KNSA $5.32
- P/E Ratio
- OFG $10.28
- KNSA N/A
- Revenue Growth
- OFG N/A
- KNSA 59.45
- 52 Week Low
- OFG $33.15
- KNSA $17.38
- 52 Week High
- OFG $47.66
- KNSA $30.69
- Technical
- Relative Strength Index (RSI)
- OFG 66.48
- KNSA 54.29
- Support Level
- OFG $42.19
- KNSA $27.62
- Resistance Level
- OFG $43.01
- KNSA $29.23
- Average True Range (ATR)
- OFG 0.80
- KNSA 1.03
- MACD
- OFG 0.13
- KNSA -0.21
- Stochastic Oscillator
- OFG 98.48
- KNSA 46.99
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.